Search :
Sign in or Register  
Welcome Sign in or Don't have an account?Register

Mouse Anti-ERCC2 Recombinant Antibody (CBYCX-102) (CBMAB-X0017-YC)


See all ERCC2 antibodies
Online Inquiry

Summary

Host Animal
Mouse
Specificity
Human
Clone
CBYCX-102
Antibody Isotype
IgG1
Application
WB, IP, FC

Basic Information

Specificity
Human
Antibody Isotype
IgG1
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Storage
Store at 4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

Full Name
ERCC Excision Repair 2, TFIIH Core Complex Helicase Subunit
Introduction
ERCC2 has ATP-dependent DNA helicase activity and belongs to the RAD3/XPD subfamily of helicases. ERCC2 is involved in transcription-coupled nucleotide excision repair and is an integral member of the basal transcription factor BTF2/TFIIH complex. Defects in ERCC2 can result in three different disorders, the cancer-prone syndrome xeroderma pigmentosum complementation group D, trichothiodystrophy, and Cockayne syndrome. ERCC2 might have a role in aging process and could play a causative role in the generation of skin cancers.
Entrez Gene ID
2068
UniProt ID
P18074
Alternative Names
EM9; TTD; XPD; TTD1; COFS2; TFIIH
Research Area
ATP-dependent 5'-3' DNA helicase, component of the general transcription and DNA repair factor IIH (TFIIH) core complex, which is involved in general and transcription-coupled nucleotide excision repair (NER) of damaged DNA and, when complexed to CAK, in RNA transcription by RNA polymerase II. In NER, TFIIH acts by opening DNA around the lesion to allow the excision of the damaged oligonucleotide and its replacement by a new DNA fragment. The ATP-dependent helicase activity of XPD/ERCC2 is required for DNA opening. In transcription, TFIIH has an essential role in transcription initiation. When the pre-initiation complex (PIC) has been established, TFIIH is required for promoter opening and promoter escape. Phosphorylation of the C-terminal tail (CTD) of the largest subunit of RNA polymerase II by the kinase module CAK controls the initiation of transcription. XPD/ERCC2 acts by forming a bridge between CAK and the core-TFIIH complex. Involved in the regulation of vitamin-D receptor activity. As part of the mitotic spindle-associated MMXD complex it plays a role in chromosome segregation. Might have a role in aging process and could play a causative role in the generation of skin cancers.
Biological Process
Aging Source: Ensembl
Apoptotic process Source: UniProtKB
Bone mineralization Source: Ensembl
Cell population proliferation Source: Ensembl
Central nervous system myelin formation Source: Ensembl
Chromosome segregation Source: UniProtKB
Embryonic cleavage Source: Ensembl
Embryonic organ development Source: Ensembl
Erythrocyte maturation Source: Ensembl
Extracellular matrix organization Source: Ensembl
Hair cell differentiation Source: UniProtKB
Hair follicle maturation Source: Ensembl
Hematopoietic stem cell differentiation Source: Ensembl
In utero embryonic development Source: Ensembl
Maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) Source: Ensembl
Multicellular organism growth Source: Ensembl
Nucleotide-excision repair Source: MGI
Nucleotide-excision repair, DNA duplex unwinding Source: GO_Central
Nucleotide-excision repair, DNA incision Source: UniProtKB
Positive regulation of DNA binding Source: Ensembl
Positive regulation of mitotic recombination Source: GO_Central
Post-embryonic development Source: Ensembl
Regulation of mitotic cell cycle phase transition Source: UniProtKB
Response to hypoxia Source: Ensembl
Response to oxidative stress Source: UniProtKB
Response to UV Source: GO_Central
Spinal cord development Source: Ensembl
Transcription by RNA polymerase II Source: UniProtKB
Transcription-coupled nucleotide-excision repair Source: UniProtKB
Transcription elongation from RNA polymerase I promoter Source: Ensembl
UV protection Source: MGI
Cellular Location
Nucleus; Spindle
Involvement in disease
Xeroderma pigmentosum complementation group D (XP-D):
An autosomal recessive pigmentary skin disorder characterized by solar hypersensitivity of the skin, high predisposition for developing cancers on areas exposed to sunlight and, in some cases, neurological abnormalities. The skin develops marked freckling and other pigmentation abnormalities. Some XP-D patients present features of Cockayne syndrome, including cachectic dwarfism, pigmentary retinopathy, ataxia, decreased nerve conduction velocities. The phenotype combining xeroderma pigmentosum and Cockayne syndrome traits is referred to as XP-CS complex.
Trichothiodystrophy 1, photosensitive (TTD1):
A form of trichothiodystrophy, an autosomal recessive disease characterized by sulfur-deficient brittle hair and multisystem variable abnormalities. The spectrum of clinical features varies from mild disease with only hair involvement to severe disease with cutaneous, neurologic and profound developmental defects. Ichthyosis, intellectual and developmental disabilities, decreased fertility, abnormal characteristics at birth, ocular abnormalities, short stature, and infections are common manifestations. There are both photosensitive and non-photosensitive forms of the disorder. TTD1 patients manifest cutaneous photosensitivity.
Cerebro-oculo-facio-skeletal syndrome 2 (COFS2):
A disorder of prenatal onset characterized by microcephaly, congenital cataracts, facial dysmorphism, neurogenic arthrogryposis, growth failure and severe psychomotor retardation. COFS is considered to be part of the nucleotide-excision repair disorders spectrum that include also xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome.
PTM
ISGylated.
More Infomation

Ura, H., Togi, S., Hatanaka, H., & Niida, Y. (2022). Establishment of a human induced pluripotent stem cell line, KMUGMCi003-A, from a patient with trichothiodystrophy 1 (TTD1) bearing compound heterozygous missense mutations in the ERCC2 gene. Stem Cell Research, 64, 102885.

Salari, N., Rasoulpoor, S., Shabani, S., Mansouri, K., Bokaee, S., Fatahian, R., ... & Hosseinian-Far, M. (2022). ERCC2 rs13181 Polymorphism Association with Glioma Risk: an Update Meta-Analysis. Indian Journal of Surgical Oncology, 1-9.

Ma, J., Shao, X., Geng, F., Liang, S., Yu, C., & Zhang, R. (2022). Ercc2/Xpd deficiency results in failure of digestive organ growth in zebrafish with elevated nucleolar stress. Iscience, 25(9), 104957.

Kapoor, S., Gustafson, T., Zhang, M., Chen, Y. S., Li, J., Nguyen, N., ... & Dashwood, R. H. (2021). Deacetylase plus bromodomain inhibition downregulates ERCC2 and suppresses the growth of metastatic colon cancer cells. Cancers, 13(6), 1438.

Duran, G., Cruz, R., Aguín, S., Barros, F., Giráldez, J. M., Bernárdez, B., ... & Lamas, M. J. (2021). Predictive value of ERCC2, ABCC2 and MMP2 of response and long-term survival in locally advanced head and neck cancer patients treated with chemoradiotherapy. Cancer Chemotherapy and Pharmacology, 88(5), 813-823.

Balkan, E., Bilici, M., Gundogdu, B., Aksungur, N., Kara, A., Yasar, E., ... & Ozturk, G. (2020). ERCC2 Lys751Gln rs13181 and XRCC2 Arg188His rs3218536 gene polymorphisms contribute to susceptibility of colon, gastric, liver, lung and prostate cancer. Journal Of Buon, 25(1), 574-81.

Zhang, H., Li, Y., Guo, S., Wang, Y., Wang, H., Lu, D., ... & Li, J. (2020). Effect of ERCC2 rs13181 and rs1799793 polymorphisms and environmental factors on the prognosis of patients with lung cancer. American journal of translational research, 12(10), 6941.

Zhao, Y., Zhao, E., Zhang, J., Chen, Y., Ma, J., & Li, H. (2019). A comprehensive evaluation of the association between polymorphisms in XRCC1, ERCC2, and XRCC3 and Prognosis in Hepatocellular Carcinoma: A Meta-Analysis. Journal of oncology, 2019.

Li, Q., Damish, A. W., Frazier, Z., Liu, D., Reznichenko, E., Kamburov, A., ... & Mouw, K. W. (2019). ERCC2 Helicase Domain Mutations Confer Nucleotide Excision Repair Deficiency and Drive Cisplatin Sensitivity in Muscle-Invasive Bladder CancerERCC2 Functional Profiling in Bladder Cancer. Clinical Cancer Research, 25(3), 977-988.

Li, M., Zhao, Y., Zhao, E., Wang, K., Lu, W., & Yuan, L. (2018). Predictive value of two polymorphisms of ERCC2, rs13181 and rs1799793, in clinical outcomes of chemotherapy in gastric cancer patients: a meta-analysis. Disease Markers, 2018.

Ask a question We look forward to hearing from you.
0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Loading...
Have you used Mouse Anti-ERCC2 Recombinant Antibody (CBYCX-102)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Learn more

Documents

Request bulk or custom quoteOnline Inquiry
Second antibody and isotype control

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Online Inquiry